Sridhar
Venkatesh,
General Manager and President
(Corporation)
Learn more...
Registrants are required to submit a monthly communication report for each oral and arranged communication with a designated public office holder. The name of the most senior paid officer (i.e. the registrant) will appear on all in-house monthly communication reports, whether or not he/she participated in the communication.
Note: Monthly Communication Reports are due on the 15th day of each month for communications that took place in the previous month.
Results below are sorted by posted date, beginning with the most recent.
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Philip Jennings,
Deputy Minister
|
Innovation, Science and Economic Development Canada (ISED)
-
François-Philippe Champagne,
Minister
|
Innovation, Science and Economic Development Canada (ISED)
-
Laurel Chester,
Sr Advisor
| Minister of Innovation, Science and Industry
|
Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication:
Health,
Research and Development,
Economic Development
Communication date:
2024-11-29
Posted date:
2024-12-16
Communication number:
5088-624281
(amended from
5088-624278)
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Erin Henry,
Director General
| Centre for Immunization Programs
|
Public Health Agency of Canada (PHAC)
-
Jacqueline Kosche,
Director, Vaccine Logistics and Operations
|
Public Health Agency of Canada (PHAC)
-
Natalie Gravelle,
A/ Director
| Centre for Immunization Programs
|
Public Health Agency of Canada (PHAC)
Subject Matter of the communication:
Health
Communication date:
2024-11-27
Posted date:
2024-12-16
Communication number:
5088-625162
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Mohamed-Iqbal Ravalia,
Senator
|
Senate of Canada
Subject Matter of the communication:
Government Procurement,
Health,
Budget,
Economic Development
Communication date:
2024-11-27
Posted date:
2024-12-16
Communication number:
5088-624050
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Amanda Ratz,
Senior Advisor
| Deputy Minister's Office
|
Health Canada (HC)
-
Jill Norman ,
Director
| Centre for Communicable Diseases and Infection Control
|
Health Canada (HC)
-
Greg Orencsak,
Deputy Minister
|
Health Canada (HC)
Subject Matter of the communication:
Government Procurement,
Health,
Immigration,
Budget,
Economic Development
Communication date:
2024-11-26
Posted date:
2024-12-16
Communication number:
5088-623995
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Eshan Naik,
Director of Policy
| Minister's office
|
Health Canada (HC)
-
Mark Holland,
Minister of Health
|
Health Canada (HC)
Subject Matter of the communication:
Government Procurement,
Health,
Budget,
Economic Development
Communication date:
2024-11-26
Posted date:
2024-12-16
Communication number:
5088-623994
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Loic Pare,
Regional Affairs Advisor
|
Public Services and Procurement Canada (PSPC)
-
Jean-Yves Duclos,
Member of Parliament
|
House of Commons
Subject Matter of the communication:
Government Procurement,
Health
Communication date:
2024-11-22
Posted date:
2024-12-16
Communication number:
5088-623913
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Simon Young,
Senior Policy Analyst
| Life Sciences and Biomanufacturing Branch
|
Innovation, Science and Economic Development Canada (ISED)
-
Kasondra White,
Director
| Office of Life Sciences and Biomanufacturing Readiness
|
Innovation, Science and Economic Development Canada (ISED)
-
Bryan Dalphy,
Deputy Director
| Life Sciences and Biomanufacturing Branch
|
Innovation, Science and Economic Development Canada (ISED)
-
Heather Earle,
Manager
| Life Sciences and Biomanufacturing Branch
|
Innovation, Science and Economic Development Canada (ISED)
-
Ritu Banerjee,
Assistant Deputy Minister
| Director General's Office
|
Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication:
Health
Communication date:
2024-11-05
Posted date:
2024-12-16
Communication number:
5088-620076
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Kathleen Dunn,
Senior advisor
|
Public Health Agency of Canada (PHAC)
-
Nesreen Mandanas,
Policy Analyst
|
Public Health Agency of Canada (PHAC)
-
Dylan Kovacs,
Policy analyst
|
Public Health Agency of Canada (PHAC)
-
Joshua Atkinson,
Project Manager
|
Public Health Agency of Canada (PHAC)
-
Bronwen Clark-Brewin,
Policy Analyst
|
Public Health Agency of Canada (PHAC)
-
Christina Surujballi ,
Senior Policy Analyst
|
Public Health Agency of Canada (PHAC)
-
Niyi Lawuyi,
Manager of Supply Access and Logistics
|
Public Health Agency of Canada (PHAC)
-
Jacqueline Arthur,
Director, innovative Supply Solutions: AMR, CVTR
|
Public Health Agency of Canada (PHAC)
Subject Matter of the communication:
Government Procurement,
Health,
Budget,
Economic Development
Communication date:
2024-10-24
Posted date:
2024-11-15
Communication number:
5088-619025
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Melissa Sutherland,
A/ Director General
| Pandemic Preparation Coordination Office
|
Health Canada (HC)
-
Michelle Boudreau ,
Executive Director
| Strategic Policy Branch
|
Health Canada (HC)
-
Greg Orencsak,
Deputy Minister
|
Health Canada (HC)
Subject Matter of the communication:
Health,
Economic Development
Communication date:
2024-10-15
Posted date:
2024-11-15
Communication number:
5088-618560
(amended from
5088-618559)
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Rodrigo Arancibia,
Director
| Life Science Industries Directorate
|
Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication:
Health
Communication date:
2024-10-01
Posted date:
2024-11-15
Communication number:
5088-615888
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Bryan Dalphy,
Deputy Director
| Life Sciences and Biomanufacturing Branch
|
Innovation, Science and Economic Development Canada (ISED)
-
Kasondra White,
Director
| Office of Life Sciences and Biomanufacturing Readiness
|
Innovation, Science and Economic Development Canada (ISED)
-
Ritu Banerjee,
Assistant Deputy Minister
| Director General's Office
|
Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication:
Health,
Economic Development
Communication date:
2024-09-26
Posted date:
2024-10-15
Communication number:
5088-615565
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Shuvaloy Majumdar,
Member of Parliament
|
House of Commons
Subject Matter of the communication:
Health,
Economic Development
Communication date:
2024-09-24
Posted date:
2024-10-15
Communication number:
5088-615452
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Mohamed-Iqbal Ravalia,
Senator
|
Senate of Canada
Subject Matter of the communication:
Health
Communication date:
2024-09-24
Posted date:
2024-10-15
Communication number:
5088-615418
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Yasir Naqvi,
Member of Parliament
|
House of Commons
Subject Matter of the communication:
Health
Communication date:
2024-09-23
Posted date:
2024-10-15
Communication number:
5088-615378
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Rodrigo Arancibia,
Director
| Life Science Industries Directorate
|
Innovation, Science and Economic Development Canada (ISED)
-
Joel Denis,
Director General
| Centre for Vaccine and Therapeutics Readiness
|
Public Health Agency of Canada (PHAC)
-
Greg Orencsak ,
Deputy Minister
|
Health Canada (HC)
-
Eric Costen,
Associate Deputy Minister
| Office of the Associate Deputy Minister
|
Health Canada (HC)
Subject Matter of the communication:
Health,
Research and Development,
Economic Development
Communication date:
2024-09-19
Posted date:
2024-10-15
Communication number:
5088-615344
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Pamela Aung-Thin,
Assistant Deputy Minister
| Health Products and Food Branch
|
Health Canada (HC)
Subject Matter of the communication:
Health
Communication date:
2024-09-10
Posted date:
2024-10-15
Communication number:
5088-614511
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Christina Jensen,
Manager, Canadian Immunization Guide
| National Advisory Committee on Immunization Secretariat
|
Public Health Agency of Canada (PHAC)
-
Jacqueline Kosche ,
Director
| Vaccine Logistics and Operations
|
Public Health Agency of Canada (PHAC)
-
Erin Henry,
Director General
| Centre for Immunization Programs and Surveillance
|
Public Health Agency of Canada (PHAC)
-
Joel Denis,
Director General
| Centre for Vaccine and Therapeutics Readiness
|
Public Health Agency of Canada (PHAC)
Subject Matter of the communication:
Health
Communication date:
2024-08-19
Posted date:
2024-09-16
Communication number:
5088-613501
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Eshan Naik,
Director of Policy
| Minister's office
|
Health Canada (HC)
Subject Matter of the communication:
Health
Communication date:
2024-08-14
Posted date:
2024-09-16
Communication number:
5088-612849
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Fatima Asghar,
Policy Advisor
|
Health Canada (HC)
-
Ella Alvarado De Catleugh ,
Intern
|
Health Canada (HC)
Subject Matter of the communication:
Health
Communication date:
2024-07-22
Posted date:
2024-08-15
Communication number:
5088-611604
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Ophelia John,
Policy Advisor
| Office of the Minister of Health
|
Health Canada (HC)
Subject Matter of the communication:
Health
Communication date:
2024-07-11
Posted date:
2024-08-15
Communication number:
5088-610284
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Judith Seidman,
Senator
|
Senate of Canada
Subject Matter of the communication:
Health
Communication date:
2024-06-26
Posted date:
2024-07-15
Communication number:
5088-609321
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Cid Cabillan,
Policy Advisor
|
Immigration, Refugees and Citizenship Canada (IRCC)
Subject Matter of the communication:
Health
Communication date:
2024-06-25
Posted date:
2024-07-15
Communication number:
5088-609276
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Mohamed-Iqbal Ravalia,
Senator
|
Senate of Canada
Subject Matter of the communication:
Health
Communication date:
2024-06-19
Posted date:
2024-07-15
Communication number:
5088-609065
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Tom Kmiec,
Member of Parliament
|
House of Commons
Subject Matter of the communication:
Health
Communication date:
2024-06-13
Posted date:
2024-07-15
Communication number:
5088-607371
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Caroline Menard,
Manager
|
Innovation, Science and Economic Development Canada (ISED)
-
Jocelyn Milburn,
Director
| Office of Life Sciences and Biomanufacturing Readiness
|
Innovation, Science and Economic Development Canada (ISED)
-
Rodrigo Arancibia,
Director
| Life Science Industries Directorate
|
Innovation, Science and Economic Development Canada (ISED)
-
Ritu Banerjee,
Assistant Deputy Minister
| Director General's Office
|
Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication:
Health,
Economic Development
Communication date:
2024-06-04
Posted date:
2024-07-15
Communication number:
5088-606104
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Joanna Lam,
Policy Advisor
| Minister's Office
|
Indigenous Services Canada (ISC)
Subject Matter of the communication:
Health
Communication date:
2024-05-30
Posted date:
2024-06-15
Communication number:
5088-605533
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Kelsey Young,
Deputy Executive Secretary
| NACI
|
Public Health Agency of Canada (PHAC)
-
Heather Deehan,
Executive Director, Vaccine Distribution and Logistics
|
Public Health Agency of Canada (PHAC)
-
Joel Denis,
Director General
| Centre for Vaccine and Therapeutics Readiness
|
Public Health Agency of Canada (PHAC)
-
Erin Henry,
Director General
|
Public Health Agency of Canada (PHAC)
Subject Matter of the communication:
Health
Communication date:
2024-05-17
Posted date:
2024-06-15
Communication number:
5088-605174
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Rodrigo Arancibia,
Director
| Life Science Industries Directorate
|
Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication:
Health,
Economic Development
Communication date:
2024-04-30
Posted date:
2024-05-15
Communication number:
5088-601821
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Semhar Zerat,
Director
| Programs and Partnerships Division
|
Public Health Agency of Canada (PHAC)
Subject Matter of the communication:
Health
Communication date:
2024-04-16
Posted date:
2024-05-15
Communication number:
5088-601822
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Laurel Chester,
Senior Advisor
|
Innovation, Science and Economic Development Canada (ISED)
-
Jaxson Khan,
Sr Policy Advisor
| MINISTER OF INNOVATION, SCIENCE AND INDUSTRY
|
Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication:
Government Procurement,
Health,
Economic Development
Communication date:
2024-04-16
Posted date:
2024-05-15
Communication number:
5088-600955
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Colin Deacon,
Senator
|
Senate of Canada
Subject Matter of the communication:
Economic Development
Communication date:
2024-04-16
Posted date:
2024-05-15
Communication number:
5088-600954
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Francis Bilodeau,
Associate Deputy Minister
| Office of the Associate Deputy Minister
|
Innovation, Science and Economic Development Canada (ISED)
-
Andrea Johnston,
Assistant deputy Minister
|
Innovation, Science and Economic Development Canada (ISED)
-
Etienne-Rene Massie,
Assistant Deputy Minister
|
Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication:
Health,
Research and Development,
Economic Development
Communication date:
2024-04-15
Posted date:
2024-05-15
Communication number:
5088-600953
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Mark Schaan,
Senior Assistant Deputy Minister
| Strategy and Innovation Policy Sector - Assistant Deputy Minister's Office
|
Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication:
Health,
Research and Development,
Economic Development
Communication date:
2024-04-15
Posted date:
2024-05-15
Communication number:
5088-600952
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Joel Denis,
Director General
| Centre for Vaccine and Therapeutics Readiness
|
Public Health Agency of Canada (PHAC)
Subject Matter of the communication:
Health
Communication date:
2024-04-04
Posted date:
2024-05-15
Communication number:
5088-599236
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Anita Anand,
President of the Treasury Board
| President's Office
|
Treasury Board Of Canada Secretariat (TBS)
Subject Matter of the communication:
Health,
Budget
Communication date:
2024-03-15
Posted date:
2024-04-15
Communication number:
5088-597887
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Qasir Hanif,
Director of Stakeholder Relations
| Minister's Office
|
Global Affairs Canada (GAC)
-
Aram Shoujounian,
Policy Advisor
| Minister's Office
|
Global Affairs Canada (GAC)
-
Matthew Trnkus,
Senior Advisor
| Minister's Office
|
Global Affairs Canada (GAC)
Subject Matter of the communication:
Health
Communication date:
2024-02-13
Posted date:
2024-03-15
Communication number:
5088-594057
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Eshan Naik,
Director of Policy
| Minister's office
|
Health Canada (HC)
-
Ophelia John,
Policy Advisor
| Office of the Minister of Health
|
Health Canada (HC)
Subject Matter of the communication:
Health
Communication date:
2024-02-13
Posted date:
2024-03-15
Communication number:
5088-592784
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Paul Moen,
Chief of Staff
|
Employment and Social Development Canada (ESDC)
-
Lhori Webster,
Director of Policy
|
Employment and Social Development Canada (ESDC)
Subject Matter of the communication:
Health
Communication date:
2024-01-26
Posted date:
2024-02-15
Communication number:
5088-591256
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Jocelyn Milburn,
Director
| Office of Life Sciences and Biomanufacturing Readiness
|
Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication:
Economic Development
Communication date:
2024-01-22
Posted date:
2024-02-15
Communication number:
5088-591666
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Victor Kandasamy,
Policy Advisor
|
Public Services and Procurement Canada (PSPC)
Subject Matter of the communication:
Government Procurement
Communication date:
2024-01-16
Posted date:
2024-02-15
Communication number:
5088-590987
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Ophelia John,
Policy Advisor
| Minister's Office
|
Health Canada (HC)
Subject Matter of the communication:
Government Procurement,
Health
Communication date:
2024-01-09
Posted date:
2024-02-15
Communication number:
5088-589793
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Laurel Chester,
Policy Advisor
| Minister's Office
|
Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication:
Economic Development
Communication date:
2023-12-14
Posted date:
2024-01-15
Communication number:
5088-587704
(amended from
5088-587698)
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Jocelyn Milburn,
Director
| Office of Life Sciences and Biomanufacturing Readiness
|
Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication:
Economic Development
Communication date:
2023-12-13
Posted date:
2024-01-15
Communication number:
5088-587696
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Eshan Naik,
Director of Policy
| Office of the Leader of the Government in the House of Commons
|
House of Commons
-
Jean-Sebastien Bock,
Deputy Chief of Staff and Director of Policy
| Office of the Minister of Health
|
Health Canada (HC)
Subject Matter of the communication:
Health
Communication date:
2023-12-12
Posted date:
2024-01-15
Communication number:
5088-587771
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Suzy McDonald,
Associate Deputy Minister
|
Finance Canada (FIN)
Subject Matter of the communication:
Health,
Budget,
Economic Development
Communication date:
2023-12-12
Posted date:
2024-01-15
Communication number:
5088-587692
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Erin Schock,
Director, Medical Countermeasures Program
|
Public Health Agency of Canada (PHAC)
-
Joel Denis,
Director General
|
Public Health Agency of Canada (PHAC)
-
Heather Jeffrey,
President
|
Public Health Agency of Canada (PHAC)
-
Cindy Evans,
Vice President
| Emergency Management Branch
|
Public Health Agency of Canada (PHAC)
Subject Matter of the communication:
Government Procurement,
Health
Communication date:
2023-12-12
Posted date:
2024-01-15
Communication number:
5088-587688
(amended from
5088-587654)
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Jocelyn Milburn,
Director
| Office of Life Sciences and Biomanufacturing Readiness
|
Innovation, Science and Economic Development Canada (ISED)
-
Ritu Banerjee,
Assistant Deputy Minister
| Director General's Office
|
Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication:
Health,
Economic Development
Communication date:
2023-12-12
Posted date:
2024-01-15
Communication number:
5088-587686
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Stephen Lucas,
Deputy Minister
|
Health Canada (HC)
Subject Matter of the communication:
Health
Communication date:
2023-12-12
Posted date:
2024-01-15
Communication number:
5088-587646
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Jennifer Miller,
Assistant Secretary to the Cabinet
|
Privy Council Office (PCO)
Subject Matter of the communication:
Health,
Economic Development
Communication date:
2023-12-12
Posted date:
2024-01-15
Communication number:
5088-587630
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Daniel MacDonald,
Director General, Drugs for Rare Diseases
| Strategic Policy Branch
|
Health Canada (HC)
Subject Matter of the communication:
Health
Communication date:
2023-12-04
Posted date:
2024-01-15
Communication number:
5088-585709
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Mary-Rose Brown,
Director of Policy
|
Public Services and Procurement Canada (PSPC)
-
Victor Kandasamy,
Policy Advisor
|
Public Services and Procurement Canada (PSPC)
Subject Matter of the communication:
Government Procurement
Communication date:
2023-11-28
Posted date:
2023-12-15
Communication number:
5088-585120
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Joel Denis,
Director General
| Centre for Vaccine and Therapeutic Readiness
|
Public Health Agency of Canada (PHAC)
-
Milan Patel,
Director, Vaccine Supply & Assurance
|
Public Health Agency of Canada (PHAC)
Subject Matter of the communication:
Government Procurement,
Health
Communication date:
2023-11-22
Posted date:
2023-12-15
Communication number:
5088-585026
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Mohamed-Iqbal Ravalia,
Senator
|
Senate of Canada
Subject Matter of the communication:
Health
Communication date:
2023-11-08
Posted date:
2023-12-15
Communication number:
5088-581815
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Francesco Sorbara,
Member of Parliment
|
House of Commons
Subject Matter of the communication:
Health,
Economic Development
Communication date:
2023-11-06
Posted date:
2023-12-15
Communication number:
5088-581303
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Rodrigo Arancibia,
Director
| Life Science Industries Directorate
|
Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication:
Economic Development
Communication date:
2023-11-01
Posted date:
2023-12-15
Communication number:
5088-580864
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Rodrigo Arancibia,
Director
| Life Science Industries Directorate
|
Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication:
Economic Development
Communication date:
2023-10-25
Posted date:
2023-11-15
Communication number:
5088-580355
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Ophelia John,
Policy Advisor
| Office of the Minister of Health
|
Health Canada (HC)
Subject Matter of the communication:
Health
Communication date:
2023-10-25
Posted date:
2023-11-15
Communication number:
5088-580354
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Brendan Hanley,
Member of Parliament
|
House of Commons
Subject Matter of the communication:
Health
Communication date:
2023-10-20
Posted date:
2023-11-15
Communication number:
5088-580150
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Ekateryna Nova,
Policy Advisor, Seniors
| Minister's Office
|
Employment and Social Development Canada (ESDC)
Subject Matter of the communication:
Health
Communication date:
2023-10-17
Posted date:
2023-11-15
Communication number:
5088-579924
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Rodrigo Arancibia,
Director
| Life Science Industries Directorate
|
Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication:
Economic Development
Communication date:
2023-09-29
Posted date:
2023-10-16
Communication number:
5088-577394
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Simon Kennedy,
Deputy Minister
|
Innovation, Science and Economic Development Canada (ISED)
-
Rodrigo Arancibia,
Director
| Life Science Industries Directorate
|
Innovation, Science and Economic Development Canada (ISED)
-
Darryl Patterson,
Director General
| Biomanufacturing Strategy Implementation Team
|
Innovation, Science and Economic Development Canada (ISED)
-
Joel Denis,
Director General
| Vaccine Supply and Assurance
|
Public Health Agency of Canada (PHAC)
-
Kasondra White,
Director
| Office of Life Sciences and Biomanufacturing Readiness
|
Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication:
Health,
Economic Development
Communication date:
2023-09-20
Posted date:
2023-10-16
Communication number:
5088-577107
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Marie-France Proulx,
Director of Communications
| Minister's Office
|
Public Services and Procurement Canada (PSPC)
Subject Matter of the communication:
Health,
Economic Development
Communication date:
2023-09-19
Posted date:
2023-10-16
Communication number:
5088-577036
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Rodrigo Arancibia,
Director
| Life Science Industries Directorate
|
Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication:
Health,
Economic Development
Communication date:
2023-09-13
Posted date:
2023-10-16
Communication number:
5088-576325
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Jed Graham,
Policy Advisor
|
Health Canada (HC)
-
Eshan Naik,
Director of Policy
| Minister's Office
|
Health Canada (HC)
Subject Matter of the communication:
Health
Communication date:
2023-09-11
Posted date:
2023-10-16
Communication number:
5088-575822
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Jocelyn Milburn,
Director
| Office of Life Sciences and Biomanufacturing Readiness
|
Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication:
Health,
Economic Development
Communication date:
2023-08-25
Posted date:
2023-09-15
Communication number:
5088-575302
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Eric Bourbonnais,
Director, Investment Opportunities
| Strategic Innovation Fund
|
Innovation, Science and Economic Development Canada (ISED)
-
Jocelyn Milburn,
Director, Office of Life Sciences and Biomanufacturing Readiness
|
Innovation, Science and Economic Development Canada (ISED)
-
Celine Menard,
Director General
| Financial Analysis and Oversight Branch
|
Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication:
Health,
Economic Development
Communication date:
2023-08-24
Posted date:
2023-09-15
Communication number:
5088-575301
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Rodrigo Arancibia,
Director
| Life Science Industries Directorate
|
Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication:
Health,
Economic Development
Communication date:
2023-07-31
Posted date:
2023-08-15
Communication number:
5088-573671
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Jean-Yves Duclos,
Minister of Health
|
Health Canada (HC)
-
Jamie Kippen,
Chief of Staff
|
Health Canada (HC)
-
Sandenga Yeba,
Senior Policy Advisor
| Minister's Office
|
Health Canada (HC)
Subject Matter of the communication:
Government Procurement,
Health,
Economic Development
Communication date:
2023-07-13
Posted date:
2023-08-15
Communication number:
5088-573210
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Rodrigo Arancibia,
Director
| Life Science Industries Directorate
|
Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication:
Economic Development
Communication date:
2023-06-26
Posted date:
2023-07-15
Communication number:
5088-570732
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Darryl Patterson,
Director General
| Biomanufacturing Strategy Implementation Team
|
Innovation, Science and Economic Development Canada (ISED)
-
Rodrigo Arancibia,
Director
| Life Science Industries Directorate
|
Innovation, Science and Economic Development Canada (ISED)
-
Ritu Banerjee,
Assistant Deputy Minister
| Office of Life Sciences and Biomanufacturing Readiness
|
Innovation, Science and Economic Development Canada (ISED)
-
Andy Fillmore,
Member of Parliament
|
House of Commons
Subject Matter of the communication:
Health,
Economic Development
Communication date:
2023-06-06
Posted date:
2023-07-15
Communication number:
5088-569574
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Yash Nanda,
Policy Advisor
| Minister's Office
|
Finance Canada (FIN)
Subject Matter of the communication:
Health
Communication date:
2023-05-10
Posted date:
2023-05-10
Communication number:
5088-564623
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Rodrigo Arancibia,
Director
| Life Science Industries Directorate
|
Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication:
Health,
Economic Development
Communication date:
2023-05-01
Posted date:
2023-06-15
Communication number:
5088-563898
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Bianca Hossain,
Senior Special Assistant
| Minister's Office
|
Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication:
Health,
Economic Development
Communication date:
2023-04-27
Posted date:
2023-05-15
Communication number:
5088-563613
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Jed Graham,
Policy advisor
| Minister's Office
|
Health Canada (HC)
-
Sandenga Yeba,
Senior Policy Advisor
| Minister's Office
|
Health Canada (HC)
Subject Matter of the communication:
Health
Communication date:
2023-04-27
Posted date:
2023-05-15
Communication number:
5088-563611
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Ed Morgan,
Director General
| Policy, Planning and International
|
Health Canada (HC)
Subject Matter of the communication:
Health
Communication date:
2023-04-25
Posted date:
2023-04-26
Communication number:
5088-563527
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Jo Voisin,
Assistant Deputy Minister
| Strategic Policy Branch
|
Health Canada (HC)
Subject Matter of the communication:
Health
Communication date:
2023-04-25
Posted date:
2023-04-26
Communication number:
5088-563526
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Rodrigo Arancibia,
Director
| Life Science Industries Directorate
|
Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication:
Economic Development
Communication date:
2023-03-31
Posted date:
2023-04-03
Communication number:
5088-560918
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Patrick Vaughan,
Special Assistant Communications and Stakeholder Relations Manager
| Office of the Minister of Seniors
|
Employment and Social Development Canada (ESDC)
Subject Matter of the communication:
Health
Communication date:
2023-03-16
Posted date:
2023-04-15
Communication number:
5088-560277
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Bianca Hossain,
Policy Advisor
| Minister's Office
|
Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication:
Economic Development
Communication date:
2023-02-09
Posted date:
2023-03-15
Communication number:
5088-555431
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Yash Nanda,
Policy Advisor
|
Finance Canada (FIN)
Subject Matter of the communication:
Health,
Budget
Communication date:
2023-01-31
Posted date:
2023-02-15
Communication number:
5088-554923
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Rodrigo Arancibia,
Director
| Life Science Industries Directorate
|
Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication:
Economic Development
Communication date:
2023-01-30
Posted date:
2023-02-15
Communication number:
5088-554882
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Rodrigo Arancibia,
Director
| Life Science Industries Directorate
|
Innovation, Science and Economic Development Canada (ISED)
-
Jean-Pierre Mizero,
Manager, Integration, Outreach & Partnerships
| Strategic Innovation Fund
|
Innovation, Science and Economic Development Canada (ISED)
-
Alison McConnell,
Deputy Director, Innovation Projects Directorate
| Strategic Innovation Fund
|
Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication:
Economic Development
Communication date:
2023-01-26
Posted date:
2023-02-15
Communication number:
5088-554834
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Eric Dagenais,
Senior Assistant Deputy Minister
| Assistant Deputy Minister's Office
|
Innovation, Science and Economic Development Canada (ISED)
-
Nancy Hamzawi,
Assistant Deputy Minister
| Health Products and Food Branch
|
Health Canada (HC)
-
Stephen Lucas,
Deputy Minister
|
Health Canada (HC)
Subject Matter of the communication:
Health
Communication date:
2023-01-26
Posted date:
2023-02-15
Communication number:
5088-554812
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Rodrigo Arancibia,
Director
| Life Science Industries Directorate
|
Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication:
Economic Development
Communication date:
2023-01-24
Posted date:
2023-02-15
Communication number:
5088-554724
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Sandenga Yeba,
Senior Policy Advisor
| Minister's Office
|
Health Canada (HC)
Subject Matter of the communication:
Government Procurement,
Health
Communication date:
2023-01-16
Posted date:
2023-02-15
Communication number:
5088-554243
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Rodrigo Arancibia,
Director
| Life Science Industries Directorate
|
Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication:
Research and Development,
Economic Development
Communication date:
2023-01-03
Posted date:
2023-02-15
Communication number:
5088-552822
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Bianca Hossain,
Policy Advisor
|
Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication:
Economic Development
Communication date:
2022-12-16
Posted date:
2023-01-16
Communication number:
5088-552368
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Jean-Sebastien Bock,
Director of Policy
| Office of the Minister of Health
|
Health Canada (HC)
-
Sandenga Yeba,
Senior Policy Advisor
| Minister's Office
|
Health Canada (HC)
Subject Matter of the communication:
Government Procurement,
Health
Communication date:
2022-12-01
Posted date:
2023-01-16
Communication number:
5088-548814
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Camille Benoit-Blouin,
Special Assistant
|
Economic Development and Official Languages
-
Zachary Nixon,
Senior Advisor
|
Economic Development and Official Languages
Subject Matter of the communication:
Health,
Economic Development
Communication date:
2022-11-23
Posted date:
2022-12-15
Communication number:
5088-548460
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Neor Tiku,
Student
|
Pacific Economic Development Canada (PacifiCan)
-
Jessica La Forge,
Policy Advisor
|
Pacific Economic Development Canada (PacifiCan)
-
Ashley Wright,
Chief of Staff to the Minister
|
Pacific Economic Development Canada (PacifiCan)
Subject Matter of the communication:
Health,
Research and Development,
Economic Development
Communication date:
2022-11-23
Posted date:
2022-12-15
Communication number:
5088-548459
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Chelsea Kusnick,
Director of Communications
|
Economic Development and Official Languages
-
Jessie Pierre,
Director of Policy
|
Economic Development and Official Languages
Subject Matter of the communication:
Health,
Economic Development
Communication date:
2022-11-23
Posted date:
2022-12-15
Communication number:
5088-548458
(amended from
5088-548457)
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Jamee St-Hilaire,
Regional Affairs Manager
|
Canadian Heritage (PCH)
-
Alexandre Boulé,
Directeur aux Affaires regionales pour le Lieutenant du Quebec
|
Canadian Heritage (PCH)
Subject Matter of the communication:
Health,
Economic Development
Communication date:
2022-11-23
Posted date:
2022-12-15
Communication number:
5088-548453
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Susan Fitzpatrick,
Head of the Canada Drug Agency Transition Office
|
Health Canada (HC)
Subject Matter of the communication:
Health
Communication date:
2022-10-27
Posted date:
2022-10-28
Communication number:
5088-544823
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Brendan Hanley,
Member of Parliament
|
House of Commons
Subject Matter of the communication:
Health
Communication date:
2022-10-24
Posted date:
2022-10-25
Communication number:
5088-544692
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Rodrigo Arancibia,
Director
| Life Science Industries Directorate
|
Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication:
Economic Development
Communication date:
2022-09-20
Posted date:
2022-09-20
Communication number:
5088-542166
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Jed Graham,
Policy Advisor
| Office of the Minister of Health
|
Health Canada (HC)
Subject Matter of the communication:
Health
Communication date:
2022-09-08
Posted date:
2022-09-08
Communication number:
5088-540894
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Marjolaine Provost,
Director of Communications
|
Health Canada (HC)
-
Jean-Yves Duclos,
Minister of Health
|
Health Canada (HC)
Subject Matter of the communication:
Health
Communication date:
2022-07-15
Posted date:
2022-08-12
Communication number:
5088-539625
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Marjolaine Provost,
Director of Communications
| Office of the Minister of Health
|
Health Canada (HC)
-
François-Olivier Picard,
Policy advisor
| Office of the Minister of Health
|
Health Canada (HC)
Subject Matter of the communication:
Health
Communication date:
2022-07-07
Posted date:
2022-08-12
Communication number:
5088-539627
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Michelle Boudreau ,
Executive Director
| Strategic Policy Branch
|
Health Canada (HC)
Subject Matter of the communication:
Health
Communication date:
2022-06-17
Posted date:
2022-06-30
Communication number:
5088-536504
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Michelle Boudreau,
Executive Director
| Office of Pharmaceutical Management Strategies
|
Health Canada (HC)
Subject Matter of the communication:
Health
Communication date:
2022-06-17
Posted date:
2022-06-27
Communication number:
5088-536301
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Yash Nanda,
Policy Advisor
|
Finance Canada (FIN)
Subject Matter of the communication:
Health
Communication date:
2022-06-16
Posted date:
2022-06-16
Communication number:
5088-535930
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Douglas Clark ,
Executive Director
|
Patented Medicine Prices Review Board (PMPRB)
Subject Matter of the communication:
Health
Communication date:
2022-06-01
Posted date:
2022-06-30
Communication number:
5088-536505
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
François-Olivier Picard,
Policy advisor
| Office of the Minister of Health
|
Health Canada (HC)
Subject Matter of the communication:
Health
Communication date:
2022-05-17
Posted date:
2022-05-17
Communication number:
5088-532498
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Sandenga Yeba,
Senior Policy Advisor
|
Health Canada (HC)
Subject Matter of the communication:
Health
Communication date:
2022-05-06
Posted date:
2022-05-17
Communication number:
5088-530974
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Majid Jowhari,
Member of Parliament
|
House of Commons
Subject Matter of the communication:
Health
Communication date:
2022-04-12
Posted date:
2022-05-17
Communication number:
5088-532499
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Mary-Rose Brown,
Senior Policy Advisor
| Minister's Office
|
Finance Canada (FIN)
Subject Matter of the communication:
Health
Communication date:
2022-02-16
Posted date:
2022-03-15
Communication number:
5088-523565
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Marcus Powlowski,
Member of Parliament
|
House of Commons
Subject Matter of the communication:
Health
Communication date:
2021-07-29
Posted date:
2021-08-16
Communication number:
5088-511962
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Marcus Powlowski,
Member of Parliament
|
House of Commons
Subject Matter of the communication:
Health
Communication date:
2021-05-27
Posted date:
2021-06-15
Communication number:
5088-506415
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Celine Caira,
Director of Policy
|
Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication:
Economic Development
Communication date:
2021-04-29
Posted date:
2021-05-19
Communication number:
5088-506150
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Marcus Powlowski,
Member of Parliament
|
House of Commons
Subject Matter of the communication:
Health
Communication date:
2021-04-29
Posted date:
2021-05-19
Communication number:
5088-506149
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Kathryn Nowers,
Director of Policy
| Health Minister's Office
|
Health Canada (HC)
Subject Matter of the communication:
Health
Communication date:
2020-12-11
Posted date:
2021-01-11
Communication number:
5088-492555
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Michelle Rempel,
Member of Parliament
|
House of Commons
Subject Matter of the communication:
Health
Communication date:
2020-12-04
Posted date:
2021-01-13
Communication number:
5088-492948
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Michelle Rempel,
Opposition Health Critic
| Conservative Party of Canada
|
House of Commons
Subject Matter of the communication:
Health
Communication date:
2020-12-03
Posted date:
2021-01-15
Communication number:
5088-489149
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Helen Gao,
Policy Advisor
| Office of the Minister
|
Health Canada (HC)
Subject Matter of the communication:
Health
Communication date:
2020-11-19
Posted date:
2020-12-04
Communication number:
5088-489148
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Stephanie Muccilli,
Director of Policy
| Office of the Minister for Seniors
|
Employment and Social Development Canada (ESDC)
Subject Matter of the communication:
Health
Communication date:
2020-10-07
Posted date:
2020-11-16
Communication number:
5088-485450
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Marcus Powlowski,
Member of Parliament
|
House of Commons
Subject Matter of the communication:
Health
Communication date:
2020-10-01
Posted date:
2020-10-19
Communication number:
5088-485449
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Seth Pickard,
Director of Parliamentary Affairs
| Office of the Minister of Justice
|
Justice Canada (JC)
-
Nicola Langille,
Director
| Office of the Minister of Justice
|
Justice Canada (JC)
Subject Matter of the communication:
Intellectual Property
Communication date:
2020-07-02
Posted date:
2020-07-02
Communication number:
5088-476507
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Amanda Woodley,
Assistant to the Parliamentary Secretary
| Offuce of the Minister
|
Innovation, Science and Economic Development Canada (ISED)
-
Michael Power,
Director of Parliamentary Affairs
| Office of the Minister
|
Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication:
Economic Development
Communication date:
2020-06-17
Posted date:
2020-06-25
Communication number:
5088-476334
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Sabina Saini,
Chief of Staff
| Office of the Minister of Health
|
Health Canada (HC)
Subject Matter of the communication:
Health
Communication date:
2020-01-10
Posted date:
2020-01-31
Communication number:
5088-463171
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Gagan Sikand,
Member of Parliament
|
House of Commons
Subject Matter of the communication:
Health,
Science and Technology
Communication date:
2019-12-18
Posted date:
2019-12-23
Communication number:
5088-462093
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Carolyn Bennett,
Minister of Indeginous and Northern Affairs
|
House of Commons
Subject Matter of the communication:
Health
Communication date:
2019-08-13
Posted date:
2019-09-16
Communication number:
5088-459789
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Amanda Woodley,
Policy Advisor
| Minister's Office
|
Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication:
Government Procurement,
Economic Development
Communication date:
2019-06-26
Posted date:
2019-07-03
Communication number:
5088-456642
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Travis Gordon,
Policy Advisor
| Health Canada, Minister's Office
|
Health Canada (HC)
Subject Matter of the communication:
Health
Communication date:
2019-05-16
Posted date:
2019-05-21
Communication number:
5088-453188
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Bill Casey,
Member of Parliament for Cumberland—Colchester
|
House of Commons
Subject Matter of the communication:
Health
Communication date:
2019-05-16
Posted date:
2019-05-21
Communication number:
5088-453187
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Senator Ravalia,
Senator, Newfoundland and Labrador
|
Senate of Canada
Subject Matter of the communication:
Health
Communication date:
2019-05-15
Posted date:
2019-05-21
Communication number:
5088-453189
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Dylan Marando,
Policy Director
| ESDC Minister’s Office
|
Employment and Social Development Canada (ESDC)
Subject Matter of the communication:
Health
Communication date:
2019-04-01
Posted date:
2019-04-01
Communication number:
5088-448741
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Daniel Lauzon,
Chief of Staff
| Minister Joly's Office (ISED)
|
Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication:
Health
Communication date:
2019-03-29
Posted date:
2019-05-21
Communication number:
5088-453186
(amended from
5088-448742)
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Gagan Sikand,
Member of Parliament
|
House of Commons
Subject Matter of the communication:
Health,
Economic Development
Communication date:
2019-01-30
Posted date:
2019-02-11
Communication number:
5088-444770
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Dev Saxena,
Senior Policy Advisor
|
Finance Canada (FIN)
Subject Matter of the communication:
Health,
Science and Technology
Communication date:
2018-11-09
Posted date:
2018-11-26
Communication number:
5088-440238
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Navdeep Bains,
Minister of Innovation, Science, and Economic Development
|
Innovation, Science and Economic Development Canada (ISED)
-
Gianluca Cairo,
Chief of Staff
|
Prime Minister's Office (PMO)
-
David McFarlane,
Director of Policy
|
Innovation, Science and Economic Development Canada (ISED)
-
Hilary Travis,
Policy Advisor
|
Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication:
Health,
Industry,
Economic Development
Communication date:
2018-09-19
Posted date:
2018-10-01
Communication number:
5088-434280
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Rick Theis,
Policy Advisor
|
Prime Minister's Office (PMO)
-
Mathieu Bouchard,
Senior Policy Advisor
|
Prime Minister's Office (PMO)
Subject Matter of the communication:
Health,
Industry,
Science and Technology,
Economic Development
Communication date:
2018-07-12
Posted date:
2018-07-23
Communication number:
5088-431512
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Doug Clark,
Executive Director
| PMPRB
|
Patented Medicine Prices Review Board (PMPRB)
Subject Matter of the communication:
Health,
Science and Technology,
Research and Development,
Economic Development
Communication date:
2018-06-28
Posted date:
2018-07-05
Communication number:
5088-430073
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
John Knubley,
Deputy Minister
|
Innovation, Science and Economic Development Canada (ISED)
-
David McFarlane,
Director of Policy
|
Innovation, Science and Economic Development Canada (ISED)
-
Nancy Faraday-Smith,
Manager
| Life Science Industries Directorate
|
Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication:
Health,
Science and Technology,
Research and Development
Communication date:
2018-06-06
Posted date:
2018-06-15
Communication number:
5088-427857
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Sheryl Groenweg,
Director General
| Manufacturing and Life Sciences
|
Innovation, Science and Economic Development Canada (ISED)
-
Nancy Faraday-Smith,
Manager
| Life Science Industries Directorate
|
Innovation, Science and Economic Development Canada (ISED)
-
Colin Reynolds,
Sector Analysis Officer
| Life Science Industries Directorate
|
Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication:
Health,
Science and Technology,
Research and Development,
Economic Development
Communication date:
2018-05-14
Posted date:
2018-05-22
Communication number:
5088-427115
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Sarah Hussaini,
Special Assistant
|
Prime Minister's Office (PMO)
Subject Matter of the communication:
Health,
Industry,
Intellectual Property,
International Trade,
Economic Development
Communication date:
2018-04-30
Posted date:
2018-05-01
Communication number:
5088-424898
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Gianluca Cairo,
Chief of Staff
| Minister of Innovation, Science, and Economic Development
|
Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication:
Health,
Economic Development
Communication date:
2018-03-08
Posted date:
2018-04-09
Communication number:
5088-423287
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Travis Gordon,
Policy Advisor
| Minister's Office
|
Health Canada (HC)
Subject Matter of the communication:
Health
Communication date:
2018-03-08
Posted date:
2018-04-09
Communication number:
5088-423286
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Kimberly Elmslie,
Assistant Deputy Minister
| Infectious Disease Prevention and Control Branch
|
Public Health Agency of Canada (PHAC)
Subject Matter of the communication:
Health
Communication date:
2018-03-08
Posted date:
2018-04-09
Communication number:
5088-423280
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Mathieu Bouchard,
Senior Advisor
|
Prime Minister's Office (PMO)
-
Maxime Dea,
Policy Advisor
|
Prime Minister's Office (PMO)
Subject Matter of the communication:
Health,
Economic Development
Communication date:
2018-01-30
Posted date:
2018-02-15
Communication number:
5088-418755
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Robert Oliphant,
Member of Parliament
|
House of Commons
Subject Matter of the communication:
Health,
Taxation and Finance,
Research and Development,
Economic Development
Communication date:
2017-11-15
Posted date:
2017-11-20
Communication number:
5088-413997
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
David McFarlane,
Director of Policy
|
Innovation, Science and Economic Development Canada (ISED)
-
Hilary Travis,
Special Assistant - Policy
|
Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication:
Health,
Taxation and Finance,
Research and Development,
Economic Development
Communication date:
2017-11-14
Posted date:
2017-11-20
Communication number:
5088-413996
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Gagan Sikand,
Member of Parliament
|
House of Commons
Subject Matter of the communication:
Health,
Taxation and Finance,
Research and Development,
Economic Development
Communication date:
2017-11-09
Posted date:
2017-11-20
Communication number:
5088-413994
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Caroline Pitfield,
Director of Policy
|
Health Canada (HC)
-
Monique Lugli,
Senior Advisor
|
Health Canada (HC)
Subject Matter of the communication:
Health,
Research and Development,
Economic Development
Communication date:
2017-11-06
Posted date:
2017-11-20
Communication number:
5088-413992
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Kathryn Nowers,
Policy Advisor
|
Health Canada (HC)
Subject Matter of the communication:
Health,
Intellectual Property,
Science and Technology,
Research and Development,
Economic Development
Communication date:
2017-10-30
Posted date:
2017-10-31
Communication number:
5088-410991
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Maxime Dea,
Policy Advisor
|
Prime Minister's Office (PMO)
Subject Matter of the communication:
Health,
Intellectual Property,
Research and Development,
Economic Development
Communication date:
2017-10-30
Posted date:
2017-10-31
Communication number:
5088-410990
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Tyler Meredith,
Policy Advisor
|
Prime Minister's Office (PMO)
Subject Matter of the communication:
Health,
Intellectual Property,
Research and Development,
Economic Development
Communication date:
2017-10-02
Posted date:
2017-10-31
Communication number:
5088-410989
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Hilary Travis,
Special Assistant (Policy)
|
Innovation, Science and Economic Development Canada (ISED)
-
Parvinder Sachdeva,
Policy Advisor
|
Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication:
Health,
Intellectual Property,
International Trade,
Research and Development,
Economic Development
Communication date:
2017-10-02
Posted date:
2017-10-31
Communication number:
5088-410986
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Douglas Clark,
Executive Director
|
Patented Medicine Prices Review Board (PMPRB)
Subject Matter of the communication:
Consumer Issues,
Health,
Intellectual Property,
Research and Development
Communication date:
2016-07-14
Posted date:
2016-08-15
Communication number:
5088-382428
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Navdeep Bains,
Minister of Innovation, Science and Economic Development Canada
|
Innovation, Science and Economic Development Canada (ISED)
-
John Knubley,
Deputy Minister of Innovation, Science and Economic Development Canada
|
Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication:
Health,
Industry,
Intellectual Property,
Internal Trade,
Science and Technology,
Research and Development,
Economic Development
Communication date:
2016-06-06
Posted date:
2016-07-15
Communication number:
5088-381398
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Simon Kennedy,
Deputy Minister
|
Health Canada (HC)
Subject Matter of the communication:
Health,
Intellectual Property
Communication date:
2016-04-14
Posted date:
2016-06-08
Communication number:
5088-378423
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Greg Taylor,
Chief Public Health Officer
|
Public Health Agency of Canada (PHAC)
-
Krista Outhwaite,
Associate Deputy Minister
|
Public Health Agency of Canada (PHAC)
Subject Matter of the communication:
Government Procurement,
Health
Communication date:
2014-12-17
Posted date:
2015-01-15
Communication number:
5088-344009
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Barbara Glover,
Assistant Deputy Minister
| Departmental Oversight Branch
|
Public Works and Government Services Canada
Subject Matter of the communication:
Government Procurement
Communication date:
2014-12-09
Posted date:
2015-01-15
Communication number:
5088-344007
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Lynette Corbett,
Chief of Staff
| Minister's Office
|
Public Works and Government Services Canada
-
Ryan Greer,
Senior Policy Advisor
| Minister's Office
|
Public Works and Government Services Canada
-
Tim Oracheski,
Director, Policy
| Minister's Office
|
Public Works and Government Services Canada
Subject Matter of the communication:
Government Procurement
Communication date:
2014-10-31
Posted date:
2014-11-17
Communication number:
5088-339048
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Claire Caloren,
Associate ADM,
| Acquisitions
|
Public Works and Government Services Canada
-
Barbara Glover,
ADM
| Departmental Oversight
|
Public Works and Government Services Canada
Subject Matter of the communication:
Government Procurement
Communication date:
2014-10-31
Posted date:
2014-11-17
Communication number:
5088-339047
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Kelvin Ogilvie,
Honourable Senator
|
Senate of Canada
Subject Matter of the communication:
Health
Communication date:
2014-06-18
Posted date:
2014-07-15
Communication number:
5088-330045
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Ed Holder,
MINISTER OF STATE, SCIENCE AND TECHNOLOGY
|
Industry Canada
Subject Matter of the communication:
Science and Technology
Communication date:
2014-04-02
Posted date:
2014-07-15
Communication number:
5088-330046
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Blake Richards,
Member of Parliament
|
House of Commons
Subject Matter of the communication:
Health
Communication date:
2013-11-18
Posted date:
2013-12-19
Communication number:
5088-311529
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Diane Finley,
Minister
|
Human Resources and Skills Development Canada (HRSDC)
-
Adria Minsky,
Director of Policy
|
Human Resources and Skills Development Canada (HRSDC)
-
Ann Matejicka,
Chief of Staff
|
Human Resources and Skills Development Canada (HRSDC)
-
Frank Vermaeten,
Assistant Deputy Minister
|
Human Resources and Skills Development Canada (HRSDC)
Subject Matter of the communication:
Labour
Communication date:
2013-02-07
Posted date:
2013-02-19
Communication number:
5088-260150
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Christian Paradis,
Minister
|
Industry Canada
-
Sophie Arvanitis,
Director of Policy
|
Industry Canada
Subject Matter of the communication:
Economic Development
Communication date:
2013-02-07
Posted date:
2013-02-19
Communication number:
5088-260132
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Lise Anne Jackson,
Policy Analyst- Trade
|
Foreign Affairs and International Trade Canada (DFAITC)
-
Patrick McIntyre,
Policy Analyst
|
Industry Canada
Subject Matter of the communication:
Economic Development
Communication date:
2013-02-06
Posted date:
2013-02-19
Communication number:
5088-260131
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Simon Kennedy,
Deputy Minister of International Trade
|
Foreign Affairs and International Trade Canada (DFAITC)
Subject Matter of the communication:
Economic Development
Communication date:
2013-02-06
Posted date:
2013-02-19
Communication number:
5088-260130
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Scott Brison,
Member of Parliament
|
House of Commons
-
Roger Cuzner,
Member of Parliament
|
House of Commons
-
Geoff Regan,
Member of Parliament
|
House of Commons
Subject Matter of the communication:
Economic Development
Communication date:
2013-02-06
Posted date:
2013-02-19
Communication number:
5088-260129
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Ailish Campbell,
Director General
| manufacturing and Life Sciences Branch
|
Industry Canada
Subject Matter of the communication:
Economic Development
Communication date:
2013-01-16
Posted date:
2013-02-19
Communication number:
5088-260152
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Tom Ring,
Assistant Deputy Minister
| Public Procurement
|
Public Works and Government Services Canada
Subject Matter of the communication:
Health
Communication date:
2012-11-29
Posted date:
2012-12-13
Communication number:
5088-250341
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Rainier Englehardt,
Assistant Deputy Minister
| Infectious Diseases
|
Public Health Agency of Canada (PHAC)
Subject Matter of the communication:
Health
Communication date:
2012-11-22
Posted date:
2012-12-13
Communication number:
5088-250340
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Greg Taylor,
Acting Chief Public Health Officer
|
Public Health Agency of Canada (PHAC)
Subject Matter of the communication:
Health
Communication date:
2012-11-22
Posted date:
2012-12-13
Communication number:
5088-250339
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Glenda Yeates,
Deputy Minister
|
Health Canada (HC)
-
Krista Outhwaite,
Associate Deputy Minister
|
Public Health Agency of Canada (PHAC)
Subject Matter of the communication:
Health
Communication date:
2012-11-22
Posted date:
2012-12-13
Communication number:
5088-250337
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Paul Glover,
Assistant Deputy Minister
| Health products and Food Branch
|
Health Canada (HC)
Subject Matter of the communication:
Health
Communication date:
2012-11-22
Posted date:
2012-12-13
Communication number:
5088-250336
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Karl Belanger,
Chief of Staff
| Official Leader of the Opposition
|
House of Commons
Subject Matter of the communication:
Health
Communication date:
2012-11-13
Posted date:
2012-12-13
Communication number:
5088-250334
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Kristen Hillman,
Chief Negotiator
| TransPacific Partnership, International Trade Canada
|
Foreign Affairs and International Trade Canada (DFAITC)
Subject Matter of the communication:
International Trade
Communication date:
2012-10-05
Posted date:
2012-11-14
Communication number:
5088-244982
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Jen Petersen,
Parliamentary Assistant
| Office of Helen Laverdiere, MP For Laurier- Sainte Marie
|
House of Commons
-
Miriam Rycroft,
Policy Analyst
| NDP OLO Parliamentary Affairs
|
House of Commons
Subject Matter of the communication:
International Development
Communication date:
2012-10-02
Posted date:
2012-11-14
Communication number:
5088-244983
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
John Knubley,
Deputy Minister
|
Industry Canada
-
Simon Kennedy,
Associate Deputy Minister
|
Industry Canada
-
Phil Jennings,
Assistant Deputy Minister
|
Industry Canada
Subject Matter of the communication:
Industry
Communication date:
2012-09-26
Posted date:
2012-10-12
Communication number:
5088-240686
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Paul Glover,
Assistant Deputy Minister
| Health Products and Food Branch
|
Health Canada (HC)
-
Rainier Englehardt,
Assistant Deputy Minister
| Infectious Diseases
|
Public Health Agency of Canada (PHAC)
Subject Matter of the communication:
Health
Communication date:
2012-09-26
Posted date:
2012-10-12
Communication number:
5088-240685
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Shuvaloy Majumdar,
Senior Policy Advisor
| Office of the Minister
|
Foreign Affairs and International Trade Canada (DFAITC)
-
Idee Inyangudor,
Senior Policy Advisor
| Canadian International Development Agency
|
Foreign Affairs and International Trade Canada (DFAITC)
Subject Matter of the communication:
International Development
Communication date:
2012-09-21
Posted date:
2012-10-15
Communication number:
5088-241054
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Brian Storseth,
Member of Parliament
|
House of Commons
Subject Matter of the communication:
International Development
Communication date:
2012-06-21
Posted date:
2012-07-20
Communication number:
5088-231289
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Ian Stewart,
ADM Strategic Policy
|
Industry Canada
-
Simon Kennedy,
Associate DM
|
Industry Canada
-
Phil Jennings,
Associate ADM
|
Industry Canada
Subject Matter of the communication:
Science and Technology,
Research and Development
Communication date:
2012-06-21
Posted date:
2012-07-20
Communication number:
5088-231272
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Ben Lobb,
Member of Parliament
|
House of Commons
Subject Matter of the communication:
International Development
Communication date:
2012-06-19
Posted date:
2012-07-20
Communication number:
5088-231271
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Jonathon Finkelstein,
Senior Tax Adviser, Minister of Finance's office
|
Finance Canada (FIN)
Subject Matter of the communication:
Financial Institutions
Communication date:
2012-06-15
Posted date:
2012-07-20
Communication number:
5088-231270
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Scott Armstrong,
Member of Parliament
|
House of Commons
Subject Matter of the communication:
International Development
Communication date:
2012-06-12
Posted date:
2012-07-20
Communication number:
5088-231269
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Ed Fast,
Minister of Foreign Affairs and International Trade
|
Foreign Affairs and International Trade Canada (DFAITC)
-
Lise-Ann Jackson,
Senior Advisor, Policy and Stakeholder Relations, office of the Minister
|
Foreign Affairs and International Trade Canada (DFAITC)
Subject Matter of the communication:
International Trade
Communication date:
2012-05-28
Posted date:
2012-06-12
Communication number:
5088-226469
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Drew Campbell,
Director of Stakeholder Relations
|
Prime Minister's Office (PMO)
-
David Belous,
Advisor, Stakeholder Relations
|
Prime Minister's Office (PMO)
-
Bruce Winchester,
Director of Policy, Office of the Minister of Industry
|
Industry Canada
-
Frank Beaudry,
Policy Advisor, Office of the Minister of Finance
|
Finance Canada (FIN)
Subject Matter of the communication:
International Trade
Communication date:
2012-05-28
Posted date:
2012-06-12
Communication number:
5088-226465
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Don Stephenson,
Chief Negotiator (Comprehensive Economic Partnership Agreement with India)
|
Foreign Affairs and International Trade Canada (DFAITC)
Subject Matter of the communication:
International Trade
Communication date:
2012-05-28
Posted date:
2012-06-12
Communication number:
5088-226464
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Rob Stewart,
ADM, International Trade and Finance
|
Finance Canada (FIN)
Subject Matter of the communication:
International Trade
Communication date:
2012-05-28
Posted date:
2012-06-12
Communication number:
5088-226462
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Rob Merrifield,
Member of Parliament, Chair of Standing Committee on International Trade
|
House of Commons
Subject Matter of the communication:
International Trade
Communication date:
2012-05-28
Posted date:
2012-06-12
Communication number:
5088-226460
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Danya Vered,
Policy Analyst, Office of the Liberal Leader
|
House of Commons
Subject Matter of the communication:
International Development
Communication date:
2012-03-13
Posted date:
2012-04-13
Communication number:
5088-217869
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Gary Goodyear,
Minister of State, Science and Technology
|
House of Commons
Subject Matter of the communication:
Health
Communication date:
2012-03-06
Posted date:
2012-04-13
Communication number:
5088-217852
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Lisa Raitt,
Minister of Labour
|
Human Resources and Skills Development Canada (HRSDC)
Subject Matter of the communication:
International Trade
Communication date:
2012-03-02
Posted date:
2012-04-13
Communication number:
5088-217850
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Steve Verheul,
Chief Negotiator CETA
|
Foreign Affairs and International Trade Canada (DFAITC)
Subject Matter of the communication:
International Trade
Communication date:
2012-03-02
Posted date:
2012-04-13
Communication number:
5088-217848
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Richard Dicerni,
Deputy Minister
|
Industry Canada
Subject Matter of the communication:
International Trade
Communication date:
2012-03-02
Posted date:
2012-03-05
Communication number:
5088-210359
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Lisa Raitt,
Member of Parliament
|
House of Commons
Subject Matter of the communication:
Labour
Communication date:
2012-03-02
Posted date:
2012-03-05
Communication number:
5088-210358
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Leona Aglukkaq,
Minister of Health
|
Health Canada (HC)
-
Scott Tessier,
Chief of Staff to Minister
|
Health Canada (HC)
-
Paul Glover,
Assistant Deputy Minister
|
Health Canada (HC)
-
Abby Hoffman,
Assistant Deputy Minister
|
Health Canada (HC)
-
Amanda Gordon,
Executive Assistant to the Minister of Health
|
Health Canada (HC)
Subject Matter of the communication:
Health,
Industry,
Intellectual Property,
International Trade
Communication date:
2012-03-01
Posted date:
2012-04-13
Communication number:
5088-217828
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Leona Aglukkaq,
Minister
|
Health Canada (HC)
-
Scott Tessier,
Chief of Staff to Minister
|
Health Canada (HC)
Subject Matter of the communication:
Health
Communication date:
2012-03-01
Posted date:
2012-03-05
Communication number:
5088-210357
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Kelvin Ogilvie,
Senator
|
Senate of Canada
Subject Matter of the communication:
Health
Communication date:
2012-02-29
Posted date:
2012-03-05
Communication number:
5088-210356
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Tom Ring,
Assistant Deputy Minister
|
Public Works and Government Services Canada
Subject Matter of the communication:
Health
Communication date:
2012-02-29
Posted date:
2012-03-05
Communication number:
5088-210329
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Aaron Seal,
Director of Policy
|
Finance Canada (FIN)
Subject Matter of the communication:
Health,
Industry,
Intellectual Property,
International Trade
Communication date:
2012-02-28
Posted date:
2012-03-05
Communication number:
5088-210355
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Sean O'Leary,
Policy Analyst
|
Industry Canada
Subject Matter of the communication:
Health,
Industry,
Intellectual Property,
International Trade
Communication date:
2012-02-28
Posted date:
2012-03-05
Communication number:
5088-210354
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Andre Bachand,
Senior Advisor
|
Prime Minister's Office (PMO)
-
Sean Speer,
Senior Economic Policy Advisor
|
Prime Minister's Office (PMO)
-
Andrea van Vugt,
Policy Advisor
|
Prime Minister's Office (PMO)
-
Phil Harwood,
Policy Advisor
|
Prime Minister's Office (PMO)
-
Stefan Stefanov,
Intern
|
Prime Minister's Office (PMO)
Subject Matter of the communication:
Health,
Industry,
Intellectual Property,
International Trade
Communication date:
2012-02-28
Posted date:
2012-03-05
Communication number:
5088-210328
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Rick Theis,
Policy Analyst, Liberal Leader's Office
|
House of Commons
Subject Matter of the communication:
International Development
Communication date:
2012-02-24
Posted date:
2012-03-05
Communication number:
5088-210353
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Jordan Leichnitz,
Policy Analyst, NDP Leader's Office
|
House of Commons
Subject Matter of the communication:
International Development
Communication date:
2012-02-23
Posted date:
2012-03-05
Communication number:
5088-210352
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Scott Tessier,
Chief of Staff to Minister
|
Health Canada (HC)
Subject Matter of the communication:
International Trade
Communication date:
2012-02-21
Posted date:
2012-03-05
Communication number:
5088-210351
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Devinder Shory,
Member of Parliament
|
House of Commons
-
Rob Merrifield,
Member of Parliament
|
House of Commons
-
Russ Hiebert,
Member of Parliament
|
House of Commons
-
Ed Holder,
Member of Parliament
|
House of Commons
Subject Matter of the communication:
International Trade
Communication date:
2012-02-15
Posted date:
2012-02-17
Communication number:
5088-208227
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Drew Capbell,
Director of Stakeholder Relations
|
Prime Minister's Office (PMO)
-
Jeannie Smith,
Chief of Staff to Minister of State, Science and Technology
|
Industry Canada
-
Ian West,
Chief of Staff, Minister
|
Canada Revenue Agency (CRA)
-
Sophia Arvanitis,
Senior Analyst
|
Finance Canada (FIN)
Subject Matter of the communication:
Taxation and Finance,
Research and Development
Communication date:
2012-02-15
Posted date:
2012-02-17
Communication number:
5088-208207
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Bernard Valcourt,
Member of Parliament
|
House of Commons
-
Dean Allison,
Member of Parliament
|
House of Commons
-
Mark Adler,
Member of Parliament
|
House of Commons
-
Jay Aspin,
Member of Parliament
|
House of Commons
-
Colin Carrie,
Member of Parliament
|
House of Commons
-
Vincent Caron,
Policy Advisor & Caucus Liaison
|
Atlantic Canada Opportunities Agency (ACOA)
Subject Matter of the communication:
Taxation and Finance,
Research and Development
Communication date:
2012-02-15
Posted date:
2012-02-17
Communication number:
5088-208188
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Richard Dicerni,
Deputy Minister
|
Industry Canada
Subject Matter of the communication:
International Trade
Communication date:
2012-02-09
Posted date:
2012-03-05
Communication number:
5088-210350
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Kirsty Duncan,
Member of Parliament
|
House of Commons
Subject Matter of the communication:
Health
Communication date:
2012-02-09
Posted date:
2012-03-05
Communication number:
5088-210349
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Tim Sargent,
Assistant Secretary to the Cabinet Economic and Regional Development Policy
|
Privy Council Office (PCO)
Subject Matter of the communication:
International Trade
Communication date:
2012-02-09
Posted date:
2012-03-05
Communication number:
5088-210347
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Ed Fast,
Member of Parliament, Minister
|
House of Commons
-
Maxime Bernier,
Member of Parliament, Minister
|
House of Commons
Subject Matter of the communication:
International Trade
Communication date:
2012-02-03
Posted date:
2012-03-05
Communication number:
5088-210330
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Glenda Yeates,
Deputy Minister
|
Health Canada (HC)
-
Paul Glover,
Assistant Deputy Minister
|
Health Canada (HC)
Subject Matter of the communication:
Health
Communication date:
2012-01-17
Posted date:
2012-02-15
Communication number:
5088-207384
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Scott Tessier,
Chief of Staff to the Minister of Health
|
Health Canada (HC)
Subject Matter of the communication:
Health
Communication date:
2012-01-10
Posted date:
2012-02-15
Communication number:
5088-207383
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Christian Paradis,
Minister
|
Industry Canada
-
Sean O'Leary,
Policy Advisor
|
Industry Canada
-
Bruce Winchester,
Director of Policy
|
Industry Canada
-
Jillian Andrews,
Policy Advisor
|
Industry Canada
Subject Matter of the communication:
Industry,
International Trade
Communication date:
2011-12-08
Posted date:
2011-12-08
Communication number:
5088-197359
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Ed Fast,
Minister of Trade
|
Foreign Affairs and International Trade Canada (DFAITC)
-
Louise Girouard,
Director of Trade MINO
|
Foreign Affairs and International Trade Canada (DFAITC)
Subject Matter of the communication:
Industry,
International Trade
Communication date:
2011-12-08
Posted date:
2011-12-08
Communication number:
5088-197350
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Bob Rae,
Member of Parliament
|
House of Commons
-
John McCallum,
Member of Parliament
|
House of Commons
-
Scott Brison,
Member of Parliament
|
House of Commons
-
Ted Tsu,
Member of Parliament
|
House of Commons
-
Joyce Murray,
Member of Parliament
|
House of Commons
-
Geoff Regan,
Member of Parliament
|
House of Commons
Subject Matter of the communication:
Industry,
International Trade
Communication date:
2011-12-08
Posted date:
2011-12-08
Communication number:
5088-197349
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Steven Farber,
Policy Advisor
|
Foreign Affairs and International Trade Canada (DFAITC)
Subject Matter of the communication:
International Development
Communication date:
2011-12-07
Posted date:
2012-01-18
Communication number:
5088-203848
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
David Wilks,
Member of Parliament
|
House of Commons
-
Mike Wallace,
Member of Parliament
|
House of Commons
-
James Rajotte,
Member of Parliament
|
House of Commons
Subject Matter of the communication:
International Trade
Communication date:
2011-12-07
Posted date:
2011-12-08
Communication number:
5088-197370
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Gerald Keddy,
Member of Parliament
|
House of Commons
-
Ron Cannan,
Member of Parliament
|
House of Commons
-
Ed Holder,
Member of Parliament
|
House of Commons
-
Rob Clarke,
Member of Parliament
|
House of Commons
Subject Matter of the communication:
Industry,
International Trade
Communication date:
2011-11-15
Posted date:
2011-12-08
Communication number:
5088-197369
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Benoit Violette,
Senior Policy Advisor
|
Industry Canada
Subject Matter of the communication:
Health,
Industry,
Intellectual Property,
International Trade
Communication date:
2011-11-15
Posted date:
2011-12-08
Communication number:
5088-197366
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Patrick McIntyre,
Director of Policy
|
Industry Canada
Subject Matter of the communication:
Health,
Industry,
Intellectual Property,
International Trade
Communication date:
2011-11-15
Posted date:
2011-12-08
Communication number:
5088-197365
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Gary Goodyear,
Minister of State, Science and Technology
|
Industry Canada
Subject Matter of the communication:
Health,
Industry,
Intellectual Property,
International Trade
Communication date:
2011-11-15
Posted date:
2011-12-08
Communication number:
5088-197364
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Rob Merrifield,
Member of Parliament
|
House of Commons
Subject Matter of the communication:
International Trade
Communication date:
2011-11-14
Posted date:
2011-12-09
Communication number:
5088-197445
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Jim Sillyer,
Member of Parliament
|
House of Commons
Subject Matter of the communication:
Health
Communication date:
2011-11-14
Posted date:
2011-12-08
Communication number:
5088-197368
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Jordan Leichnitz,
Policy Advisor, Office of the Leader of the Official Opposition
|
House of Commons
Subject Matter of the communication:
International Development
Communication date:
2011-11-14
Posted date:
2011-12-08
Communication number:
5088-197362
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Lisa Raitt,
Minister of Labour
|
Human Resources and Skills Development Canada (HRSDC)
-
Brad Butt,
Member of Parliament
|
House of Commons
Subject Matter of the communication:
Research and Development
Communication date:
2011-11-10
Posted date:
2011-12-08
Communication number:
5088-197361
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Helene Laverdiere,
Member of Parliament
|
House of Commons
-
Jennifer Peterson,
Parliamentary Assistant to Helene Laverdiere
|
House of Commons
-
Rahmat Kassam,
Legislative Assistant to Mobina Jaffer
|
Senate of Canada
-
Jordan Leichnitz,
Policy Advisor, Office of the Leader of the Official Opposition
|
House of Commons
Subject Matter of the communication:
International Development
Communication date:
2011-11-08
Posted date:
2011-12-08
Communication number:
5088-197360
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Mobina Jaffer,
Senator
|
Senate of Canada
-
Rahmat Kassam,
Legislative Assistant to Mobina Jaffer
|
Senate of Canada
Subject Matter of the communication:
International Development
Communication date:
2011-10-28
Posted date:
2011-11-15
Communication number:
5088-194777
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Ron Cannan,
Member of Parliament
|
House of Commons
-
Ed Holder,
Member of Parliament
|
House of Commons
Subject Matter of the communication:
International Trade
Communication date:
2011-10-26
Posted date:
2012-02-17
Communication number:
5088-208147
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Devinder Shory,
Member of Parliament
|
House of Commons
Subject Matter of the communication:
International Trade
Communication date:
2011-10-24
Posted date:
2012-02-17
Communication number:
5088-208107
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Jennifer Peterson,
Parliamentary Assistant to Helene Laverdiere
|
House of Commons
Subject Matter of the communication:
International Development
Communication date:
2011-10-21
Posted date:
2011-11-15
Communication number:
5088-194775
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Helene Laverdiere,
Member of Parliament
|
House of Commons
Subject Matter of the communication:
International Development
Communication date:
2011-10-19
Posted date:
2011-11-15
Communication number:
5088-194772
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Louis Levesque,
Deputy Minister
|
Foreign Affairs and International Trade Canada (DFAITC)
Subject Matter of the communication:
International Trade
Communication date:
2011-10-18
Posted date:
2011-11-11
Communication number:
5088-193338
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Steve Verheul,
Chief Negotiator
|
Foreign Affairs and International Trade Canada (DFAITC)
Subject Matter of the communication:
International Trade
Communication date:
2011-10-18
Posted date:
2011-11-11
Communication number:
5088-193337
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Simon Kennedy,
Associate Deputy Minister
|
Industry Canada
Subject Matter of the communication:
International Trade
Communication date:
2011-10-18
Posted date:
2011-11-11
Communication number:
5088-193336
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Richard Dicerni,
Deputy Minister
|
Industry Canada
Subject Matter of the communication:
International Trade
Communication date:
2011-10-18
Posted date:
2011-11-11
Communication number:
5088-193334
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Sena O'Leary,
Policy Advisor
|
Industry Canada
Subject Matter of the communication:
Health,
Industry,
Intellectual Property,
International Trade
Communication date:
2011-10-18
Posted date:
2011-11-11
Communication number:
5088-193333
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Philip Jennings,
Associate Assistant Deputy Minister
|
Industry Canada
Subject Matter of the communication:
Health,
Industry,
Intellectual Property,
International Trade
Communication date:
2011-10-18
Posted date:
2011-11-11
Communication number:
5088-193332
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Christian Paradis,
Minister
|
Industry Canada
Subject Matter of the communication:
Health,
Industry,
Intellectual Property,
International Trade
Communication date:
2011-10-18
Posted date:
2011-11-11
Communication number:
5088-193330
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Paul Glover,
Deputy Minister
|
Health Canada (HC)
Subject Matter of the communication:
Health,
Industry,
Intellectual Property,
International Trade
Communication date:
2011-10-18
Posted date:
2011-11-11
Communication number:
5088-193329
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Wayne Easter,
Member of Parliament
|
House of Commons
Subject Matter of the communication:
International Trade
Communication date:
2011-10-07
Posted date:
2011-11-15
Communication number:
5088-194770
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Raymond Cote,
Member of Parliament
|
House of Commons
Subject Matter of the communication:
International Trade
Communication date:
2011-10-07
Posted date:
2011-11-15
Communication number:
5088-194768
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Robert Chisholm,
Member of Parliament
|
House of Commons
-
Mathieu Ravignat,
Member of Parliament
|
House of Commons
Subject Matter of the communication:
Health,
Industry,
Intellectual Property,
International Trade
Communication date:
2011-09-29
Posted date:
2011-10-14
Communication number:
5088-189101
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Helen Laverdiere,
Member of Parliament
|
House of Commons
Subject Matter of the communication:
International Development
Communication date:
2011-09-28
Posted date:
2011-10-14
Communication number:
5088-189105
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
David Jones,
Public Health Officer
|
Public Health Agency of Canada (PHAC)
Subject Matter of the communication:
Health
Communication date:
2011-09-09
Posted date:
2011-10-14
Communication number:
5088-189094
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Andrea McGuigan,
Policy Advisor, Foreign Affairs, Environment & Energy Security
|
Prime Minister's Office (PMO)
Subject Matter of the communication:
Health,
Intellectual Property,
International Trade
Communication date:
2011-08-16
Posted date:
2011-09-15
Communication number:
5088-185890
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Richard Dicerni,
Deputy Minister
|
Industry Canada
Subject Matter of the communication:
Industry,
International Trade
Communication date:
2011-05-10
Posted date:
2011-06-16
Communication number:
5088-173805
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
David Butler Jones,
Chief Public Health Officer
|
Health Canada (HC)
Subject Matter of the communication:
Health
Communication date:
2011-05-10
Posted date:
2011-06-16
Communication number:
5088-173804
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Steve Verheul,
Chief Trade Negotiator, Canada-European Union
|
Foreign Affairs and International Trade Canada (DFAITC)
Subject Matter of the communication:
Health,
Industry,
Intellectual Property,
International Trade
Communication date:
2010-11-29
Posted date:
2010-12-15
Communication number:
5088-162417
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Keith Martin,
Member of Parliament
|
House of Commons
Subject Matter of the communication:
Health
Communication date:
2010-11-04
Posted date:
2010-12-15
Communication number:
5088-162410
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Marc Garneau,
Member of Parliament
|
House of Commons
Subject Matter of the communication:
Health
Communication date:
2010-11-03
Posted date:
2010-12-15
Communication number:
5088-162399
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Krista Outhwaite,
Associate Deputy Minister
| Public Health Agency of Canada
|
Public Health Agency of Canada (PHAC)
Subject Matter of the communication:
Health
Communication date:
2010-11-03
Posted date:
2010-12-15
Communication number:
5088-162393
(amended from
5088-162382)
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Rainier Englehardt,
Assistant Deputy Minister
|
Public Health Agency of Canada (PHAC)
Subject Matter of the communication:
Health
Communication date:
2010-11-03
Posted date:
2010-12-15
Communication number:
5088-162387
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Megan Leslie,
MP Halifax
|
Members of the House of Commons
Subject Matter of the communication:
Health,
Industry
Communication date:
2010-09-21
Posted date:
2010-10-16
Communication number:
5088-157032
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Carolyn Bennett,
MP St.Paul's
|
Members of the House of Commons
Subject Matter of the communication:
Health,
Industry
Communication date:
2010-09-21
Posted date:
2010-10-16
Communication number:
5088-157030
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Joy Smith,
MP Kildonan-St Paul
| Chair Standing Committee on Health
|
Members of the House of Commons
Subject Matter of the communication:
Industry
Communication date:
2010-09-21
Posted date:
2010-10-16
Communication number:
5088-157028
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Leah Canning,
Director of Policy
| Minister's Office
|
Health Canada (HC)
Subject Matter of the communication:
Industry
Communication date:
2010-09-21
Posted date:
2010-10-16
Communication number:
5088-157024
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Meena Ballantyne,
Assistant Deputy Minister
|
Health Canada (HC)
-
Tom Ring,
Assistant Deputy Minister
|
Public Works and Government Services Canada
-
Mary Chaput,
Associate Deputy Minister
|
Public Health Agency of Canada (PHAC)
-
David Butler Jones,
Chief Public Health Officer
|
Public Health Agency of Canada (PHAC)
-
Rainier Engelhardt,
Assistant Deputy Minister
|
Public Health Agency of Canada (PHAC)
Subject Matter of the communication:
Health
Communication date:
2010-08-26
Posted date:
2010-09-16
Communication number:
5088-154670
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Tom Ring,
ADM
| Acquisitions Branch
|
Public Works and Government Services Canada
-
Jane Billings,
Senior ADM
| Planning and Public Health Integration
|
Public Health Agency of Canada (PHAC)
Subject Matter of the communication:
Health
Communication date:
2010-07-28
Posted date:
2010-08-17
Communication number:
5088-153636
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Dr. David Butler-Jones,
Chief Public Health Officer
| Public Health Agency of Canada
|
Public Health Agency of Canada (PHAC)
Subject Matter of the communication:
Health
Communication date:
2010-05-25
Posted date:
2010-06-16
Communication number:
5088-149336
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Peter Van Loan,
Minister of International Trade
| Foreign Affairs and International Trade Canada
|
Foreign Affairs and International Trade Canada (DFAITC)
Subject Matter of the communication:
Health,
Industry,
Intellectual Property,
International Trade,
Science and Technology
Communication date:
2010-03-10
Posted date:
2010-04-12
Communication number:
5088-145445
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Meena Ballantyne,
Assistant Deputy Minister
| Health Canada
|
Health Canada (HC)
-
Morris Rosenberg,
Deputy Minister
| Health Canada
|
Health Canada (HC)
-
David Butler-Jones,
Chief Public Health Officer
| Public Health Agency of Canada
|
Public Health Agency of Canada (PHAC)
-
Jane Billings,
Senior Assistant Deputy Minister
| Public Health Agency of Canada
|
Public Health Agency of Canada (PHAC)
Subject Matter of the communication:
Health,
Industry
Communication date:
2010-03-10
Posted date:
2010-04-12
Communication number:
5088-145444
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Meena Ballantyne,
Assistant Deputy Minister
| Health Canada
|
Health Canada (HC)
-
Leah Canning,
Director of Policy
| MINISTER'S OFFICE
|
Health Canada (HC)
-
Mary Chaput,
Associate Deputy Minister
| OFFICE OF THE ASSOCIATE DEPUTY MINISTER
|
Public Health Agency of Canada (PHAC)
-
Jane Billings,
Senior Assistant Deputy Minister
| DEPUTY MINISTER'S OFFICE
|
Public Health Agency of Canada (PHAC)
Subject Matter of the communication:
Health
Communication date:
2010-01-25
Posted date:
2010-02-11
Communication number:
5088-136854
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Morris Rosenberg,
Deputy Minister
| DEPUTY MINISTER'S OFFICE
|
Health Canada (HC)
-
Mary Chaput,
Associate Deputy Minister
| Office of the Associate Deputy Ministr
|
Public Health Agency of Canada (PHAC)
-
Dr. David Butler-Jones,
Chief Public Health Officer
| Public Health Agency of Canada
|
Public Health Agency of Canada (PHAC)
Subject Matter of the communication:
Health
Communication date:
2010-01-14
Posted date:
2010-02-11
Communication number:
5088-136835
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Dr. David Butler-Jones,
Chief Public Health Officer
| Public Health Agency of Canada
|
Public Health Agency of Canada (PHAC)
Subject Matter of the communication:
Health
Communication date:
2009-12-21
Posted date:
2010-01-12
Communication number:
5088-134774
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Tim Vail,
Director of Communications
| Minister's Office
|
Health Canada (HC)
Subject Matter of the communication:
Health
Communication date:
2009-11-24
Posted date:
2009-12-10
Communication number:
5088-132020
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
David Butler-Jones,
Chief Public Health Officer
|
Public Health Agency of Canada (PHAC)
-
Mary Chaput,
Associate Deputy Minister
|
Public Health Agency of Canada (PHAC)
Subject Matter of the communication:
Health
Communication date:
2009-11-23
Posted date:
2009-12-10
Communication number:
5088-132019
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Sabrina Anzini,
Special Advisor, Legal Affairs and Policy
|
Prime Minister's Office (PMO)
-
Isabelle Bouchard,
Issues Management
|
Prime Minister's Office (PMO)
Subject Matter of the communication:
Health
Communication date:
2009-11-06
Posted date:
2009-12-10
Communication number:
5088-132018
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Daniel Jean,
Deputy Secretary to the Cabinet
|
Privy Council Office (PCO)
Subject Matter of the communication:
Health
Communication date:
2009-11-05
Posted date:
2009-12-10
Communication number:
5088-132017
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
David Butler-Jones,
Chief Public Health Officer
|
Public Health Agency of Canada (PHAC)
Subject Matter of the communication:
Health
Communication date:
2009-11-04
Posted date:
2009-12-10
Communication number:
5088-132016
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Sabrina Anzini,
Special Advisor, Legal Affairs and Policy
|
Prime Minister's Office (PMO)
-
Isabelle Bouchard,
Issues Management
|
Prime Minister's Office (PMO)
Subject Matter of the communication:
Health
Communication date:
2009-11-02
Posted date:
2009-12-10
Communication number:
5088-132014
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Morris Rosenberg,
Deputy Minister
|
Health Canada (HC)
-
Scott Tessier,
Chief of Staff
| Office of the Minister
|
Health Canada (HC)
Subject Matter of the communication:
Health
Communication date:
2009-10-30
Posted date:
2009-11-16
Communication number:
5088-127440
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Sabrina Anzini,
Special Advisor, Legal Affairs and Policy
|
Prime Minister's Office (PMO)
-
Isabelle Bouchard,
Issue Management
|
Prime Minister's Office (PMO)
Subject Matter of the communication:
Health
Communication date:
2009-10-29
Posted date:
2009-11-16
Communication number:
5088-127439
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Sabrina Anzini,
Special Advisor, Legal Affairs and Policy
|
Prime Minister's Office (PMO)
-
Isabelle Bouchard,
Issue Advisor
|
Prime Minister's Office (PMO)
Subject Matter of the communication:
Health
Communication date:
2009-10-21
Posted date:
2009-11-16
Communication number:
5088-127438
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
David Butler-Jones,
Chief Public Health Officer
|
Public Health Agency of Canada (PHAC)
Subject Matter of the communication:
Health
Communication date:
2009-10-21
Posted date:
2009-11-16
Communication number:
5088-127437
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
David Butler-Jones,
Chief Public Health Officer
|
Public Health Agency of Canada (PHAC)
Subject Matter of the communication:
Health
Communication date:
2009-10-07
Posted date:
2009-11-16
Communication number:
5088-127436
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
David Butler-Jones,
Chief Public Health Officer
|
Public Health Agency of Canada (PHAC)
-
Morris Rosenberg,
Deputy Minister
|
Health Canada (HC)
Subject Matter of the communication:
Health
Communication date:
2009-10-06
Posted date:
2009-11-16
Communication number:
5088-127435
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
David Butler-Jones,
Chief Public Health Officer
|
Public Health Agency of Canada (PHAC)
Subject Matter of the communication:
Health
Communication date:
2009-10-02
Posted date:
2009-11-16
Communication number:
5088-127434
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Isabelle Bouchard,
Issues Advisor
|
Prime Minister's Office (PMO)
-
Sabrina Anzini,
Special Advisor, Legal Affairs and Policy
|
Prime Minister's Office (PMO)
-
Paul Wilson,
Director, Policy
|
Prime Minister's Office (PMO)
Subject Matter of the communication:
Health
Communication date:
2009-09-11
Posted date:
2009-10-15
Communication number:
5088-124175
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Morris Rosenberg,
Deputy Minister
|
Health Canada (HC)
-
Scott Tessier,
Chief of Staff
| Office of the Minister
|
Health Canada (HC)
-
David Butler-Jones,
Chief Public Health Officer
|
Public Health Agency of Canada (PHAC)
Subject Matter of the communication:
Health
Communication date:
2009-09-11
Posted date:
2009-10-15
Communication number:
5088-124156
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Tim Vail,
Director of Communication
| Office of the Minister
|
Health Canada (HC)
Subject Matter of the communication:
Health
Communication date:
2009-09-03
Posted date:
2009-10-15
Communication number:
5088-124155
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
David Butler-Jones,
Chief Public Health Officer
|
Public Health Agency of Canada (PHAC)
Subject Matter of the communication:
Health
Communication date:
2009-09-02
Posted date:
2009-10-15
Communication number:
5088-124137
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Jane Billings,
Senior Assistant Deputy Minister
|
Public Health Agency of Canada (PHAC)
Subject Matter of the communication:
Health
Communication date:
2009-07-23
Posted date:
2009-08-14
Communication number:
5088-116694
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Meena Ballantyne,
Assistant Deputy Minister
|
Health Canada (HC)
Subject Matter of the communication:
Health
Communication date:
2009-07-21
Posted date:
2009-08-14
Communication number:
5088-116616
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
David Butler-Jones,
Chief Public Health Officer
|
Public Health Agency of Canada (PHAC)
Subject Matter of the communication:
Health
Communication date:
2009-07-14
Posted date:
2009-08-14
Communication number:
5088-116614
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
David Butler-Jones,
Chief Public Health Officer
|
Public Health Agency of Canada (PHAC)
Subject Matter of the communication:
Health
Communication date:
2009-06-29
Posted date:
2009-07-16
Communication number:
5088-111916
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
David Butler-Jones,
Chief Public Health Officer
|
Public Health Agency of Canada (PHAC)
Subject Matter of the communication:
Health
Communication date:
2009-05-21
Posted date:
2009-06-15
Communication number:
5088-107754
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Elie Salibi,
Policy Advisor
|
Industry Canada
-
Tony Clement,
Minister
|
Industry Canada
Subject Matter of the communication:
Health,
Industry,
Intellectual Property,
International Relations,
Science and Technology,
Taxation and Finance
Communication date:
2009-05-19
Posted date:
2009-06-15
Communication number:
5088-107795
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Elie Salibi,
Policy Advisor
|
Industry Canada
-
Tony Clement,
Minister
|
Industry Canada
Subject Matter of the communication:
Health,
Industry,
Intellectual Property,
International Trade,
Science and Technology,
Taxation and Finance
Communication date:
2009-05-18
Posted date:
2009-06-15
Communication number:
5088-107794
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Leah Canning,
Policy Advisor
|
Health Canada (HC)
-
Dani Shaw,
Chief of Staff
|
Health Canada (HC)
-
Morris Rosenberg,
Deputy Minister
|
Health Canada (HC)
-
Leona Aglukkaq,
Minister
|
Health Canada (HC)
-
David Butler-Jones,
Chief Public Health Officer
|
Public Health Agency of Canada (PHAC)
Subject Matter of the communication:
Health,
Industry,
Science and Technology
Communication date:
2009-05-12
Posted date:
2009-06-15
Communication number:
5088-107755
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
David Butler-Jones,
Chief Public Health Officer
|
Public Health Agency of Canada (PHAC)
Subject Matter of the communication:
Health
Communication date:
2009-05-05
Posted date:
2009-06-15
Communication number:
5088-103355
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
David Butler-Jones,
Chief Public Health Officer
|
Public Health Agency of Canada (PHAC)
Subject Matter of the communication:
Health
Communication date:
2009-04-22
Posted date:
2009-05-13
Communication number:
5088-103354
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
David Butler-Jones,
Chief Public Health Officer
|
Public Health Agency of Canada (PHAC)
Subject Matter of the communication:
Health,
Industry,
Science and Technology
Communication date:
2009-03-27
Posted date:
2009-04-14
Communication number:
5088-100467
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Meena Ballantyne,
Assistant Deputy Minister
| Health Products and Food Branch
|
Health Canada (HC)
Subject Matter of the communication:
Health,
Industry,
Science and Technology
Communication date:
2009-03-25
Posted date:
2009-04-14
Communication number:
5088-100466
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Leah Canning,
Policy Advisor
| Office of the Minister
|
Health Canada (HC)
-
Benoit Violette,
Senior Policy Advisor
| Office of the Minister
|
Industry Canada
-
William King,
Chief of Staff
| Office of the Minister
|
Industry Canada
Subject Matter of the communication:
Consumer Issues,
Health,
Industry,
Intellectual Property,
International Trade,
Science and Technology,
Taxation and Finance
Communication date:
2009-01-22
Posted date:
2009-02-11
Communication number:
5088-92894
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Dr. Danielle Grondin,
A/ Assistant Deputy Minister
|
Public Health Agency of Canada (PHAC)
-
Dr. David Butler-Jones,
Chief Public Health Officer
|
Public Health Agency of Canada (PHAC)
-
Meena Ballantyne,
Assistant Deputy Minister
| Health Products & Food Branch
|
Health Canada (HC)
-
Morris Rosenberg,
Deputy Minister
|
Health Canada (HC)
Subject Matter of the communication:
Health,
Industry,
Science and Technology
Communication date:
2009-01-21
Posted date:
2009-02-11
Communication number:
5088-92896
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
David Butler-Jones,
Chief Public Health Officer
|
Public Health Agency of Canada (PHAC)
Subject Matter of the communication:
Health,
Industry,
Science and Technology
Communication date:
2009-01-21
Posted date:
2009-02-11
Communication number:
5088-92895
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Morris Rosenberg,
Deputy Minister
|
Health Canada (HC)
Subject Matter of the communication:
Health,
Industry,
Science and Technology
Communication date:
2008-12-23
Posted date:
2009-01-15
Communication number:
5088-89135
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Richard Dicerni,
Deputy Minister
|
Industry Canada
Subject Matter of the communication:
Health,
Industry,
Science and Technology
Communication date:
2008-12-22
Posted date:
2009-01-15
Communication number:
5088-84035
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Brien Benoit,
Chairperson
|
Patented Medicine Prices Review Board (PMPRB)
Subject Matter of the communication:
Consumer Issues,
Health,
Industry,
Science and Technology
Communication date:
2008-10-21
Posted date:
2008-11-14
Communication number:
5088-84034
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Richard Dicerni,
Deputy Minister
|
Industry Canada
Subject Matter of the communication:
Health,
Industry,
Science and Technology
Communication date:
2008-10-20
Posted date:
2008-11-14
Communication number:
5088-83414
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Tony Clement,
Minister of Health
|
Health Canada (HC)
Subject Matter of the communication:
Health
Communication date:
2008-08-17
Posted date:
2008-09-15
Communication number:
5088-80114
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Laurie Throness,
Policy Advisor
| Minister's Office
|
Health Canada (HC)
Subject Matter of the communication:
Health
Communication date:
2008-08-13
Posted date:
2008-09-15
Communication number:
5088-77894
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
David Butler-Jones,
Chief Public Health Officer
| Office of the Chief Public Health Officer
|
Public Health Agency of Canada (PHAC)
Subject Matter of the communication:
Health
Communication date:
2008-07-23
Posted date:
2008-08-14
Communication number:
5088-77485
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Suzanne Vinet,
Associate Deputy Minister
| Associate Deputy Minister's Office
|
Health Canada (HC)
-
Morris Rosenberg,
Deputy Minister of Health
| Deputy Minister's Office
|
Health Canada (HC)
Subject Matter of the communication:
Health
Communication date:
2008-07-23
Posted date:
2008-08-14
Communication number:
5088-74714
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Laurie Throness,
Policy Advisor
| Minister's Office
|
Health Canada (HC)
-
Tony Clement,
Minister of Health
| Minister's Office
|
Health Canada (HC)
Subject Matter of the communication:
Health
Communication date:
2008-07-23
Posted date:
2008-08-14
Communication number:
5088-74695
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Robert Serpe,
Policy Advisor
| Minister's Office
|
Finance Canada (FIN)
-
James Flaherty,
Minister of Health
| Minister's Office
|
Finance Canada (FIN)
Subject Matter of the communication:
Health
Communication date:
2008-07-23
Posted date:
2008-08-14
Communication number:
5088-74674
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Robert Serpe,
Policy Advisor
| Minister's Office
|
Finance Canada (FIN)
Subject Matter of the communication:
Health
Communication date:
2008-07-22
Posted date:
2008-08-14
Communication number:
5088-74694
View monthly communication report
-
GlaxoSmithKline Inc.
In-house Corporation
Designated Public Office Holders who participated in the communication:
-
Leah Canning,
Policy Advisor
| Minister's Office
|
Health Canada (HC)
Subject Matter of the communication:
Health
Communication date:
2008-07-09
Posted date:
2008-08-14
Communication number:
5088-74734
View monthly communication report